Dr. Oskarsson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4500 San Pablo Rd S
Jacksonville, FL 32224Phone+1 904-953-2903Fax+1 904-953-0757- Is this information wrong?
Summary
- I am a Neurologist working on clinical care of people with ALS and clinical research for better treatments of ALS for the future.
Education & Training
- University of ColoradoFellowship, Neuromuscular Medicine (Neurology), 2004 - 2006
- University of ColoradoResidency, Neurology, 2001 - 2004
- University of ColoradoInternship, Internal Medicine, 2000 - 2001
- Lund University Faculty of MedicineClass of 1999
Certifications & Licensure
- CA State Medical License 2008 - Present
- FL State Medical License 2016 - 2025
- CO State Medical License 2004 - 2009
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- Fellow American Academy of Neurology, 2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- DNA, Blood and Skin Cell Repository for Research on ALS and Related Neurodegenerative Disorders at Mayo Clinic Florida Start of enrollment: 2012 Sep 01
- Mexiletine for the Treatment of Muscle Cramps in ALS Start of enrollment: 2013 May 01
- Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study) Start of enrollment: 2013 May 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsSingle-cell dissection of the human motor and prefrontal cortices in ALS and FTLD.S Sebastian Pineda, Hyeseung Lee, Maria J Ulloa-Navas, Raleigh M Linville, Francisco J Garcia, Kyriakitsa Galani, Erica Engelberg-Cook, Monica C Castanedes, Brent E Fi...> ;Cell. 2024 Apr 11
- Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, Chiò A, Van Damme P, Ludolph AC, Glass JD, Andrews JA, Babu S, Benatar M, McDermott CJ, Cochrane T, Cha...> ;The New England journal of medicine.
- 1 citationsNeeds of persons living with ALS at home and their family caregivers: A scoping review.Heather M Young, Tina R Kilaberia, Robin Whitney, Benjamin M Link, Janice F Bell, Orly Tonkikh, Björn Oskarsson, Famula, J.> ;Muscle & Nerve. 2023 Sep 1
- Join now to see all
Journal Articles
- Poly(GR) Impairs Protein Translation and Stress Granule Dynamics in C9orf72-Associated Frontotemporal Dementia and Amyotrophic Lateral SclerosisDennis W Dickson, Bjorn Oskarsson, Nature
Press Mentions
- Toward Clinical Trials for One Type of ALSJanuary 2nd, 2019
- Flex Pharma Investigates FLX-787 as Treatment for Cramps in ALS PatientsAugust 2nd, 2017
- FDA Clears Flex Pharma's FLX-787 to Commence US Phase 2 Trial in ALS Under INDAugust 1st, 2017
- Join now to see all
Professional Memberships
- Member
- Fellow
Other Languages
- Swedish
Hospital Affiliations
- Mayo Clinic Hospital in FloridaJacksonville, Florida
External Links
- Mayo biohttps://www.mayoclinic.org/biographies/oskarsson-bjorn-e-m-d/bio-20257831
- Refer a patienthttp://www.mayoclinic.org/medical-professionals/provider-relations/refer-a-patient
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: